2016 American Transplant Congress
Impact of New Kidney Allocation System on Transplant Rates for Highly Sensitized Patients-Center Specific Study.
Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA.
Aim: Our renal transplant program promotes transplant of highly sensitized patients (pts) through desensitization and listing only strong antibodies as unacceptable antigens (UAs). UNOS implemented…2016 American Transplant Congress
Ureteroenterostomy in Kidney Transplant: Retrospective Analysis of 30 Consecutive Cases.
Kidney Hospital, São Paulo, Brazil.
INTRODUCTION: Lower urinary tract abnormalities are found in up to15% of adults and in 20-30% of children requiring kidney transplantation. Several will necessitate an enterocystoplasty…2016 American Transplant Congress
Kinetics of Cytomegalovirus Load in Kidney Transplant Recipients Receiving Everolimus or Mycophenolate Sodium and No Pharmacological Prophylaxis.
Hospital do Rim, São Paulo, Brazil.
The purpose of this analysis is to investigate the kinetics of cytomegalovirus (CMV) viral load in kidney transplant recipients receiving tacrolimus (TAC) plus everolimus (EVR)…2016 American Transplant Congress
HCV, Acute Rejection, and the New Direct-Acting Antivirals in Deceased Donor Kidney Transplant Recipients.
The association between hepatitis C virus (HCV) seropositivity and acute rejection (AR) in kidney transplant donors and recipients is unclear, and may have changed with…2016 American Transplant Congress
Alloimmunity Through Non-HLA Epitopes in Kidney Transplantation.
Introduction: An unexpected diversity in the human genome has been identified including more than 2,500 nonsynonymous single nucleotide polymorphisms (nsSNP) and up to 20 homozygous…2016 American Transplant Congress
Risk Factors for Clinical Urinary Tract Infections in Kidney Transplant Recipients with Asymptomatic Bacteriuria.
Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
BackgroundThere is no clear consensus on whether asymptomatic bacteriuria (ABU) should be treated in kidney transplant recipients (KTRs). We sought to identify patient or episode…2016 American Transplant Congress
Preservation of Alloreactive and Antiviral Immunity After Switch to Belatacept-Based Regimen After Kidney Transplantation.
Purpose: We set out to investigate the impact of switch from calcineurin inhibitor (CNI) to belatacept on T cell mediated allo- and EBV-specific immunity.Methods: We…2016 American Transplant Congress
Differences in Reported Barriers to Immunosuppression Adherence Among a Cohort of Pediatric Renal Transplant Recipients from the United States and Canada.
Aim: The purpose of this study was to examine differences in reported barriers to immunosuppressant adherence (IA) between a cohort of pediatric renal transplant recipients…2016 American Transplant Congress
Evaluation of Polyomavirus (BK) Treatment and Clinical Outcomes in Pediatric Kidney Transplant Recipients: A >10 Year Single Center Retrospective Experience.
BK viremia (BKV) is a serious infectious complication after kidney transplantation and can lead to BK nephropathy (BKN) and allograft loss. We reviewed our experience…2016 American Transplant Congress
Urinary Tract Infections During the First Year After Renal Transplantation: Risk Factors and Nomograms.
Nephrology, Regional University Hospital, Málaga, Spain.
Background: Urinary tracts infections (UTIs) are the most common infectious complications following renal transplantation (RT). The aim of this study was to evaluate the frequency…
- « Previous Page
- 1
- …
- 402
- 403
- 404
- 405
- 406
- …
- 531
- Next Page »